Sera Prognostics

Biotechnology - Salt Lake City, Utah, United States

Sera Prognostics Employees
Mike Foley

Chief Medical Officer

Contact Mike Foley

Olivia Petty

Sr. Manager, Commercial Operations

Contact Olivia Petty

Jaime Anderly

National Director, Employer Markets

Contact Jaime Anderly

Darron Segall

Sr. Director of Market Access

Contact Darron Segall

Julja Burchard

Senior Director of Bioinformatics

Contact Julja Burchard

Jeff Brohamer

Director of Information Technology

Contact Jeff Brohamer

View All Sera Prognostics Employees Contact All Sera Prognostics Employees
Sera Prognostics Details

Sera Prognostics is a leading proteomic and bioinformatics company dedicated to improving the lives of women and babies through precision biomarker-based tests designed to enhance pregnancy care. Sera's vision is to deliver pivotal information in early pregnancy to physicians, to help them to improve the health of their patients and reduce costs of healthcare delivery. Sera's PreTRM® Test reports to a physician the individualized risk of a pregnant woman to deliver prematurely, enabling earlier proactive interventions in patients with higher risk. Rigorous clinical validation of PreTRM® Test performance (accuracy of predicting premature delivery) was reported in the American Journal of Obstetrics & Gynecology in 2016 in a U.S. cohort of 5,501 patients across 11 centers. Preterm birth is defined as any birth before 37 weeks gestation and is a leading cause of illness and death in newborns. The 2020 March of Dimes Report Card shows that of nearly 4 million babies born annually in the U.S., more than one in ten is born prematurely. Prematurity is associated with a significantly increased risk of major long-term medical complications, including learning disabilities, cerebral palsy, chronic respiratory illness, intellectual disability, seizures, vision and hearing loss, and can generate significant cost throughout the lives of affected children. The annual U.S. health care costs to manage complications of prematurity were estimated at $31.5B for 2015. Sera is also developing a robust pipeline of innovative tests focused on other complications of pregnancy. Using its advanced proprietary mass spectrometry and bioinformatics platform technologies, Sera detects biologically important protein expression differences to build high performing predictions of risk for adverse pregnancy outcomes (including preterm birth, preeclampsia, gestational diabetes, growth restriction, and others).

Sera Prognostics logo, Sera Prognostics contact details
Website: pretrm.com
Employees: 51 - 200
HQ:
Location: Salt Lake City, Utah, United States
Revenue:
Sera Prognostics Technologies
Email Providers

Outlook

Marketing Automation

Pardot

Customer Relationship Management

Salesforce

CMS

WP Engine

Hosting

Google Cloud Hosting

Online Video Platforms

Vimeo

View All Technologies Used At Sera Prognostics

Contacting Sera Prognostics: Connect with Executives and Employees

Get in Touch with Sera Prognostics Executives and Employees

Connecting with Sera Prognostics's Executives and Workforce

Accessing Contact Information for Sera Prognostics Executives

Connecting with Sera Prognostics: Reach Out to Their Team

Discover How to Contact Sera Prognostics Executives and Staff

Looking to connect with Sera Prognostics executives or employees?

Seeking to Get in Touch with Sera Prognostics Executives or Staff?

Want to Reach Out to Sera Prognostics Executives or Team Members?

In Search of Contact Details for Sera Prognostics Professionals?

Connecting with Sera Prognostics: Contacting Executives and Staff

Browse companies
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z